ACI Formulations Balance Sheet Health
Financial Health criteria checks 3/6
ACI Formulations has a total shareholder equity of BDT3.2B and total debt of BDT3.1B, which brings its debt-to-equity ratio to 96.1%. Its total assets and total liabilities are BDT7.3B and BDT4.1B respectively. ACI Formulations's EBIT is BDT578.1M making its interest coverage ratio 2.8. It has cash and short-term investments of BDT104.6M.
Key information
96.1%
Debt to equity ratio
৳3.11b
Debt
| Interest coverage ratio | 2.8x |
| Cash | ৳104.55m |
| Equity | ৳3.24b |
| Total liabilities | ৳4.10b |
| Total assets | ৳7.33b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ACIFORMULA's short term assets (BDT4.7B) exceed its short term liabilities (BDT3.8B).
Long Term Liabilities: ACIFORMULA's short term assets (BDT4.7B) exceed its long term liabilities (BDT286.0M).
Debt to Equity History and Analysis
Debt Level: ACIFORMULA's net debt to equity ratio (92.9%) is considered high.
Reducing Debt: ACIFORMULA's debt to equity ratio has increased from 89.2% to 96.1% over the past 5 years.
Debt Coverage: ACIFORMULA's debt is well covered by operating cash flow (30.7%).
Interest Coverage: ACIFORMULA's interest payments on its debt are not well covered by EBIT (2.8x coverage).